Last updated: 2026-10-17 23:33:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Quanome Technologies, Inc. (QNME) operates in the ARRANGEMENT OF TRANSPORTATION OF FREIGHT & CARGO sector and is listed on NASDAQ. The stock is currently priced at $0,53, with a market capitalization of $19,59M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0,26 to $1,40. This page covers its latest market performance, valuation, price trends and company information.
$19,59M | |
$0,58 | |
$1,40 | |
$0,26 | |
$0,57 | |
578,59K | |
17,10M | |
-- | |
$1,40 | |
$0,26 | |
-- | |
-- |
Quanome Technologies, Inc. (QNME) last closed at $0,57 as of 2026-10-16 23:55:00, unchanged from the previous close of $0,57.
During the latest regular trading session, QNME traded between $0,26 and $1,40, with a volume of 578,59K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Quanome Technologies, Inc. (QNME) moved from $0,83 to $0,53, representing a decline of 36,55% ($0,30).
The stock traded between $0,52 and $0,94 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 11,45 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 23,2%
QNME is currently trading at $0,53, placing it 23,2% of the way from its 52-week low of $0,26 to its 52-week high of $1,40. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Quanome Technologies Inc operates in the midstream segment of the pharmaceutical industrial ecosystem, operating between upstream pharmaceutical manufacturers and downstream medical end customers. It sources products from multiple manufacturers and suppliers, and distribute them to hospitals, pharmaceutical distributors and other healthcare providers. Its principal product categories include infusion products, foods for special medical purposes, and specialty pharmaceuticals. It operates in one reportable segment serves its customers by providing pharmaceutical products in China. The company generates a substantial percentage of its revenue from selling pharmaceutical products on a direct basis.
| Industry | ARRANGEMENT OF TRANSPORTATION OF FREIGHT & CARGO |
| Employees | 27 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Quanome Technologies, Inc. (QNME) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.